The Biotech Growth Trust
The Company seeks capital appreciation through investment in the worldwide biotechnology industry.
Why invest in the Biotech Growth Trust?
In order to achieve its investment objective
The Biotech Growth Trust invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis.
The Biotech Growth Trust (BIOG) - Portfolio Manager Presentation
March 2026
Listen to Portfolio Manager, Geoffrey Hsu, provide investors with an update on BIOG's recent performance and how the portfolio is positioned to try and take advantage of the current long-term opportunities across the global biotechnolgy sector.
Share price
View share price detail
Factsheets
How to invest
The Company’s shares are traded openly on the London Stock Exchange and can be purchased through a stock broker or other financial intermediary.
£282.9m
Our Net Asset Value*
Source: Frostrow Capital LLP
*As at 31 December 2025
Register for email alerts
Read the latest Regulatory News Service (RNS) announcements from The Biotech Growth Trust.
Sign up to The Biotech Growth Trust mailing list for our monthly factsheet.
Investor Disclosure Document